First AD

Second AD

professor of clinical neurology, and George A. Zimmermann Endowed Professor in Multiple Sclerosis, Department of Neurology, University of California San Francisco

Professor of neurology, and associate chief, Multiple Sclerosis Division, Hospital of the University of Pennsylvania

Staff neurologist, Unity Health Toronto–St Michael's Hospital; assistant professor, University of Toronto

Saunders Family Professor of Neurology, and director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine, Mount Sinai

Staff neurologist, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic

Clinical Subtypes of MS 

Diagnosing SPMS

Classification and Diagnosis of SPMS

Treating PPMS Versus SPMS 

Siponimod for SPMS Treatment  

MS Treatment: EXPAND Study Versus ASCEND Study 

Progressive MS Treatment: Ocrelizumab

Patient Selection in MS Treatment 

Peer Exchange

Videos

Multiple Sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

Kristen Krysko, MD, summarizes the results of the phase III ORATORIO trial and discusses the rationale for using ocrelizumab for the treatment of progressive multiple sclerosis.  

Experts discuss the diagnosis and treatment of progressive multiple sclerosis.